The FDA has ordered manufacturers to immediately pull all prescription and over-the-counter versions of the heartburn medication Zantac, citing concern that a contaminant poses a cancer risk.
, explained in a statement Wednesday."However, since we don't know how or for how long the product might have been stored, we decided that it should not be available to consumers and patients unless its quality can be assured.", a company that does safety testing on popular drugs, discovered the contaminant in alarming levels.
"Our tests in lab conditions seem to pretty clearly show that the drug is able to degrade into NDMA by itself, either in the tablet or actually in the human body," Valisure founder and CEO David Light recalled in a conversation with NPRThe FDA said Wednesday that it is sending letters to all ranitidine manufacturers recommending that they pull their products from the market.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA orders all Zantac heartburn products off store shelvesAll Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, FDA says.
Lire la suite »
The FDA Pulls Heartburn Drug Zantac From Stores Amid Carcinogen ConcernsThe carcinogen NDMA was found in ranitidine (Zantac), with levels increasing dangerously over time and in high storage temperatures.
Lire la suite »
FDA says there's a shortage of hydroxychloroquine and chloroquine 'due to a significant surge in demand'The drugs are being used experimentally to treat COVID-19 patients.
Lire la suite »
The FDA says a popular heartburn drug should be pulled off store shelves.All Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, FDA says.
Lire la suite »
The Biggest Non-Coronavirus Stories You Missed Today: Trump Says Iran Is Planning A ‘Sneak Attack,’ FDA Pulls Heartburn Drug ZantacI’m a San Francisco-based reporter covering breaking news at Forbes. Previously, I’ve reported for USA Today, Business Insider, The San Francisco Business Times and San Jose Inside. I studied journalism at Syracuse University’s S.I. Newhouse School of Public Communications and was an editor at The Daily Orange, the university’s independent student newspaper. Follow me on Twitter rachsandl or shoot me an email rsandlerforbes.com.
Lire la suite »